Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Oncogene
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. oncogene
  3. original paper
  4. article
Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location
Download PDF
  • Original Paper
  • Published: 27 February 1997

Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location

  • Kristen C Hart2 &
  • Daniel J Donoghue1 

Oncogene volume 14, pages 945–953 (1997)Cite this article

  • 672 Accesses

  • 24 Citations

  • Metrics details

Abstract

To examine the ability of ras to activate signal transduction pathways in the absence of lipid modifications, fusion proteins were constructed that target rasWT or activated ras61L to cellular membranes as integral membrane proteins, using the first transmembrane domain of the E1 protein of avian infectious bronchitis virus (IBV), which contains a cis-Golgi targeting signal. Golgi-targeted derivatives of activated ras were completely inactive in transformation assays. However, when examined in focus formation assays, transformation of NIH3T3 cells were seen with derivatives of ras61L containing a mutated E1 targeting sequence that results in plasma membrane localization. Removal of the lipid modification sites in and upstream of the CAAX motif did not abrogate the transforming activity of plasma membrane-localized ras61L derivatives, indicating that these lipid modifications are not essential for ras activity, as long as the protein is correctly localized to the plasma membrane. Interestingly, the activity of integral membrane versions of ras61L was strictly dependent on a minimum distance between the transmembrane domain anchor region and the coding sequence of ras. Derivatives with only a 3-amino acid linker were inactive, while linkers of either 11- or 22-amino acids were sufficient to restore transforming activity. These results demonstrate that: (1) activated ras targeted to Golgi membranes is unable to cause transformation; (2) lipid modifications at the C-terminus are not required for the transforming activity of plasma membrane-anchored ras61L derivatives, and serve primarily a targeting function; (3) a transmembrane domain can effectively substitute for C-terminal modifications that would normally target ras to the inner surface of the plasma membrane, indicating that ras61L does not need to reversibly dissociate from the membrane as might be allowed by the normal lipidation; and (4) in order to function properly, there exists a critical distance that the ras protein must reside from the plasma membrane.

You have full access to this article via your institution.

Download PDF

Similar content being viewed by others

TGFβ-induced changes in membrane curvature influence Ras oncoprotein membrane localization

Article Open access 05 August 2022

Membrane lipids drive formation of KRAS4b-RAF1 RBDCRD nanoclusters on the membrane

Article Open access 28 February 2024

Plasma membrane integrity in health and disease: significance and therapeutic potential

Article Open access 19 January 2021

Article PDF

Author information

Authors and Affiliations

  1. Department of Chemistry and Biochemistry, Center for Molecular Genetics, University of California, San Diego, La Jolla, 92093-0367, California, USA

    Daniel J Donoghue

  2. Molecular Pathology Program, School of Medicine, University of California, San Diego, La Jolla, 92093-0367, California, USA

    Kristen C Hart

Authors
  1. Kristen C Hart
    View author publications

    Search author on:PubMed Google Scholar

  2. Daniel J Donoghue
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hart, K., Donoghue, D. Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location. Oncogene 14, 945–953 (1997). https://doi.org/10.1038/sj.onc.1200908

Download citation

  • Received: 12 August 1996

  • Revised: 18 October 1996

  • Accepted: 22 October 1996

  • Issue date: 27 February 1997

  • DOI: https://doi.org/10.1038/sj.onc.1200908

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • ras
  • subcellular localization
  • transformation

This article is cited by

  • RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

    • Berta Casar
    • Andrew P. Badrock
    • Piero Crespo

    Nature Communications (2018)

  • Ras proteins: different signals from different locations

    • John F. Hancock

    Nature Reviews Molecular Cell Biology (2003)

  • Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

    • Kristen C Hart
    • Scott C Robertson
    • Daniel J Donoghue

    Oncogene (2000)

  • Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation

    • Arkadiusz Welman
    • Max M Burger
    • Jörg Hagmann

    Oncogene (2000)

You have full access to this article via your institution.

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • About the Editors
  • Contact
  • For Advertisers
  • Subscribe
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Oncogene (Oncogene)

ISSN 1476-5594 (online)

ISSN 0950-9232 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited